Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Carrillo

Showing results (401-410 of 522) with videos related to

Pageof 53
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2021
Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemicEmily A Meyers, Philippe Amouyel, Diane E Bovenkamp, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatmentB Joy Snider, Alessandro Biffi, Sasha Bozeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumCharles C Windon, Constantine Gatsonis, Justin Romanoff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2025
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapiesRenaud La Joie, Jeffrey L Cummings, Jeffrey L Dage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task ForceD Angioni, J Cummings, C J Lansdall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumJoseph Giorgio, Ganna Blazhenets, Jhony A Mejía-Perez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJoseph Giorgio, Ganna Blazhenets, Jhony A Mejía-Perez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Pageof 53

Showing results (401-410 of 522) with videos related to

Sort By:
Pageof 53
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2021
Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemicEmily A Meyers, Philippe Amouyel, Diane E Bovenkamp, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatmentB Joy Snider, Alessandro Biffi, Sasha Bozeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumCharles C Windon, Constantine Gatsonis, Justin Romanoff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2025
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapiesRenaud La Joie, Jeffrey L Cummings, Jeffrey L Dage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task ForceD Angioni, J Cummings, C J Lansdall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumJoseph Giorgio, Ganna Blazhenets, Jhony A Mejía-Perez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJoseph Giorgio, Ganna Blazhenets, Jhony A Mejía-Perez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Pageof 53